{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Metabolic Enzyme & Protease > Miglustat hydrochlorideCAS：210110-90-0
Molecular Formula：C10H22ClNO4
Molecular Weight：255.74
Storage：Powder:-20℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：White to light brown Solid
Qty：
Size：
| CAS | 210110-90-0 |
| Name | Miglustat hydrochloride |
| Molecular Formula | C10H22ClNO4 |
| Molecular Weight | 255.74 |
| Solubility | Soluble in Water |
| Purity | ≥98% |
| Appearance | White to light brown Solid |
| Storage | Powder:-20℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 874-729-5 |
| MDL | MFCD00269940 |
| SMILES | CCCCN1CC(C(C(C1CO)O)O)O.Cl |
| InChIKey | QPAFAUYWVZMWPR-ZSOUGHPYSA-N |
| InChI | InChI=1S/C10H21NO4.ClH/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12;/h7-10，12-15H，2-6H2，1H3;1H/t7-，8+，9-，10-;/m1./s1 |
| PubChem CID | 6603107 |
| Target Point | Ceramide glucosyltransferase |
| Passage | Metabolic Enzyme&Protease |
| Background | Miglustat hydrochloride is an orally active and reversible inhibitor of ceramide glucosyltransferase. Miglustat hydrochloride can be used in the study of type I Gaucher disease. |
| Unit | Bottle |
| Specification | 1mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
